Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous PSCT vs HiDAC in MDS/sAML
NCT00002926Phase 3Unknown
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Dec 1996
- Modality
- Stem Cell Therapies
- Countries
- 9
01
Overview
A Phase 3 trial of peripheral blood stem cells in myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), sponsored by European Organisation for Research and Treatment of Cancer. Status: unknown.
02
Drugs
peripheral blood stem cells
03
Conditions
myelodysplastic syndrome (MDS)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00002926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002926.